TiMi Robotics Secures Series B+ Funding to Accelerate Smart Hospital Solutions with Medical Robots

VCBeat (WeChat Official Account: vcbeat) has learned that Shanghai TMiRob Technology Co., Ltd. completed its Series B+ financing in the first quarter of 2019. The company did not disclose the amount raised. The investors included investment platforms under Shanghai Pudong Science and Technology Innovation Group Co., Ltd. (hereinafter referred to as “Pudong Sci-Tech Innovation”)—namely, Shanghai Zhangjiang Torch Venture Capital Co., Ltd., Shanghai Zhangjiang Haocheng Venture Capital Co., Ltd., and Shanghai Zhangjiang Sci-Tech Venture Capital Co., Ltd. (hereinafter referred to as “Zhangjiang Sci-Tech Investment”)—as well as Hangzhou Chuangtu Venture Capital Partnership (Limited Partnership) (hereinafter referred to as “Chuangtu Investment”).

This round of financing will accelerate TMiRob’s R&D in high-end medical robots and expand the application of its robots in smart hospitals. TMiRob primarily provides intelligent robotic products and solutions for the healthcare market. Since its establishment, the company has developed ten medical robot models, which have been deployed in nearly 100 hospitals. In addition to its currently deployed products—including material management and delivery robots, ward care robots, guidance robots, and disinfection robots—TMiRob will leverage its industry advantages in surgical robotics to strategically layout further R&D and applications.

Pudong Sci-Tech Innovation is a large state-owned enterprise group established by the CPC Pudong New Area Committee and the People’s Government of Pudong New Area, Shanghai. It specializes in sci-tech financial services, including fund management, venture capital, technology guarantees, technology loans, and technology incubation, exploring a capital-driven approach to foster technological entrepreneurship and industrial development. Pudong Sci-Tech Innovation primarily invests in high-tech enterprises with independent innovation capabilities, covering key industry sectors prioritized for support under national policies. Its investment portfolio includes AMEC, ASR Microelectronics, ACM Research, VeriSilicon, Chipone, Tasly, Peijia Medical, and InnoCare Pharma, among others.

Zhangjiang Haocheng is the sole platform company for industrial investment under Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. Its investment portfolio covers key technology sectors prioritized for development within Zhangjiang Science City. The cumulative investment volume has reached RMB 2.5 billion, with invested companies including Spreadtrum Communications, MicroPort Scientific Corporation, Buchang Pharmaceuticals, Wind Information, Ximalaya FM, Mindray Medical, E-House China, and Shanghai Micro Electronics Equipment (SMEE), among others.

Zhangjiang Sci-Tech Investment, a wholly-owned subsidiary of Zhangjiang Group, provides comprehensive services—including investment, incubation, loans, and training—as well as access to external resources for startups, with a commitment to facilitating the rapid growth of early-stage enterprises. Since its establishment, Zhangjiang Sci-Tech Investment has invested in nearly 100 companies, including RDA Microelectronics, E-World Technology, Anji Microelectronics, Canagene Pharmaceuticals, MicroPort Endovascular, and Qiniu Cloud, among which several have successfully completed initial public offerings (IPOs).

Chuangtu Investment is an early-stage venture capital fund managed by Shanghai Chuangtu Investment Management Co., Ltd. Focusing on the early-stage “hard tech” sector, Shanghai Chuangtu has established its own brand incubation base, “Chuangtu Jungle.” With a highly professional team and an extensive service network, the firm has invested in and supported a number of well-known startups, including TMiRob, Zongmu Technology, HiAR, and InnoGrit. It is currently collaborating with leading domestic technology R&D service institutions to jointly build the “National Chip Fire Innovation and Entrepreneurship (Zhangjiang) Base.”

Shanghai TMiRob Robotics Technology Co., Ltd., located in the Zhangjiang High-Tech Park in Shanghai, is a high-tech enterprise certified by the Shanghai Municipal Government. The company boasts a team of professionals specializing in robotic theoretical research, design, production, and marketing. It has pioneered the definition and development of a series of medical robot products, helping hospitals improve management efficiency, reduce occupational injuries among healthcare workers, and enhance patients’ medical experience. Over the past two years, TMiRob has garnered favor from numerous leading domestic investors and has taken the lead in completing multiple rounds of financing within the medical service robotics industry.

TMiRob High-Value Consumables Management Robot for Operating Rooms

TMiRob Controlled Substance Management Robot

TMiRob Intelligent Disinfection Robot